+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Allergan Ltd - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 47 Pages
  • September 2023
  • GlobalData
  • Allergan plc
  • ID: 5397259
Allergan Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The publisher's summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Allergan Ltd (Allergan), a subsidiary of AbbVie Inc, is a specialty pharmaceutical company that develops and markets branded pharmaceuticals and biosimilar, and over-the-counter (OTC) pharmaceutical products. The company offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology, women’s health, urology and anti-infective therapeutic categories. It sells its products to retailers, drug wholesalers and distributors, including national retail drug and food store chains, mail order retailers, hospitals, clinics, government agencies and managed healthcare providers such as health maintenance organizations and other institutions. It has operations across the Americas, Europe, Asia-Pacific, the Middle East, and Africa. Allergan is headquartered in Dublin, Ireland.

Allergan Ltd Key Recent Developments

  • May 25, 2022: Attorney General Morrisey announces record-breaking $161.5-plus million settlement with Teva and Allergan
  • Apr 28, 2022: Allergan, an AbbVie Company, to present new data from its leading portfolio of eye care treatments at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
  • Mar 30, 2022: Attorney General Moody secures more than $870 million from CVS, Teva, Allergan and Endo

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the publisher's detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Allergan Ltd - Key Facts
  • Allergan Ltd - Key Employees
  • Allergan Ltd - Key Employee Biographies
  • Allergan Ltd - Major Products and Services
  • Allergan Ltd - History
  • Allergan Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Allergan Ltd - Business Description
  • R&D Overview
  • Allergan Ltd - Corporate Strategy
  • Allergan Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Allergan Ltd - Strengths
  • Allergan Ltd - Weaknesses
  • Allergan Ltd - Opportunities
  • Allergan Ltd - Threats
  • Allergan Ltd - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Allergan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Allergan Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Allergan Ltd, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • May 25, 2022: Attorney General Morrisey announces record-breaking $161.5-plus million settlement with Teva and Allergan
  • Apr 28, 2022: Allergan, an AbbVie Company, to present new data from its leading portfolio of eye care treatments at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
  • Mar 30, 2022: Attorney General Moody secures more than $870 million from CVS, Teva, Allergan and Endo
Section 5 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Allergan Ltd, Key Facts
  • Allergan Ltd, Key Employees
  • Allergan Ltd, Key Employee Biographies
  • Allergan Ltd, Major Products and Services
  • Allergan Ltd, History
  • Allergan Ltd, Other Locations
  • Allergan Ltd, Subsidiaries
  • Allergan Ltd, Key Competitors
  • Allergan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Allergan Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Allergan Ltd, Recent Deals Summary
List of Figures
  • Allergan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Allergan Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Eli Lilly and Co
  • Madrigal Pharmaceuticals Inc
  • Pfizer Inc
  • Antares Pharma Inc
  • Jaguar Health Inc
  • Bristol-Myers Squibb Co
  • GSK plc
  • Malin Corporation Plc
  • Ocular Therapeutix Inc
  • Amgen Inc
  • AstraZeneca Plc
  • Cassava Sciences Inc
  • Gilead Sciences Inc